CMO of OncoMed Pharma resigns
December 6, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
OncoMed Pharmaceuticals, a clinical-stage pharmaceutical company, announced that Jakob Dupont has resigned from his positions as the company’s senior vice …
CEO of Teva’s Generics Medicines Group steps down
December 6, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva
Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
Cannabis-based treatment scores Phase 3 successes for GW Pharma
December 6, 2016Manufacturing and Production, Research and Development GW Pharma, cannabidiol
UK-based GW Pharmaceuticals, a biopharmaceutical firm focused on the development of novel cannabinoid therapies, has unveiled new efficacy data for …
CEO of Teva’s Generics Medicines Group steps down
December 6, 2016Manufacturing and Production, Medical Communications Teva, generics
Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO
December 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xenetic
Xenetic Biosciences, a clinical-stage biopharmaceutical company, has announced the appointment of Jeffrey Eisenberg as chief operating officer. Mr. Eisenberg has …
Merck and Roche extend distribution ties
December 5, 2016Manufacturing and Production Merck, Roche, distribution
Merck KGaA and Roche have announced that they will further increase the distribution links between the two companies by having …
Takeda to invest €40m in Dublin operations expansion
December 5, 2016Manufacturing and Production Dublin, Ireland, Nanlarotm, Takeda
Takeda has announced it is to invest $40 million in a new facility in Dublin, adding a new facility and …
Mission Therapeutics announces new non-executive chairman
December 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment
Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …
Scientists create ‘map of drugs’ to aid further development
December 5, 2016Manufacturing and Production, Medical Communications
Researchers at The Institute of Cancer Research have used drugs licensed through the FDA to create a map of all …
Veeva announces Veeva CRM Engage Meeting at European Commercial Summit
December 5, 2016Medical Communications Big Data, CRM, veeva
Veeva, a cloud software company, concluded its annual European Commercial Summit last week, held this year in Madrid. The conference …
FDA approves another indication for Lilly/Boehringer diabetes treatment
December 5, 2016Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance
Jardiance (empagliflozin), an oral SGLT02 inhibitor developed by Eli Lilly and distributed by Boehringer Ingelheim, has been approved by the …
Technology and patient adherence: Putting control of medication directly in patients’ hands
December 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing apps, patient adherence, technology
Ben Hargreaves looks at how apps and medical devices could reduce these figures by providing patients new ways of keeping …
ReNeuron’s stem cell therapy improves motor function in stroke study
December 5, 2016Research and Development ReNeuron, stem cell, stem cell therapy, stroke
ReNeuron, a UK-based biotechnology company, posted results of its experimental stem cell therapy for patients who had been disabled after …
Ablynx secures first €1m milestone payment from Novo Nordisk
December 5, 2016Sales and Marketing Ablynx, Novo Nordisk, nanobody
Ablynx has secured €1 million from Novo Nordisk as it hits its first discovery milestone for its multi-specific nanobody construct, …
New molecular-binding technique promises accelerated drug development
December 5, 2016Research and Development, Sales and Marketing Alzheimer's, Cancer, Indiana University-Purdue University Indianapolis
Researchers at the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) have claimed to have designed a new molecular …
Novartis posts 82% remission rate in CAR T paediatric study
December 5, 2016Research and Development, Sales and Marketing CAR T, CAR-T, Novartis, leukaemia, paediatric
Novartis has released the results of its global, paediatric study of the treatment of leukaemia in children and young adults …
Pfizer teams up with IBM Watson Health in immuno-oncology
December 2, 2016Medical Communications Pfizer, Watson, Watson Health, drug discovery, ibm
Pfizer and IBM Watson Health have announced a joint venture to accelerate research in immuno-oncology. Pfizer will use IBM’s Watson …
Top Ten most popular articles on Pharmafile this week
December 2, 2016Medical Communications November, news, pharmaceutical, top 10, top ten, top ten stories
This week has been an interesting one for pharmaceutical innovation. A number of stories and studies have arisen about trialling …
Looking back at the biggest deal of 2016: Bayer-Monsanto
December 2, 2016Medical Communications Bayer, acquisition, big deal, monsanto, pharma deal 2016
The industry followed Bayer’s attempts to acquire US agricultural firm Monsanto with fevered anticipation; the takeover eventually closed in September …
J&J hit by $1bn hip implant lawsuit
December 2, 2016Medical Communications J&J, JJ, lawsuit
Johnson & Johnson have been hit with yet another payout to patients who claim its products caused them harm. First, …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
